Polymyalgia rheumatica

M13_POLYMYALGIA

polymyalgia rheumatica: Polymyalgia rheumatica is a common inflammatory condition that often affects people over the age of 50 years. Characteristic symptoms are shoulder and hip girdle pain and prolonged morning stiffness. Markers of inflammation are often elevated.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 M35.3
Hospital discharge: ICD-9 725
Hospital discharge: ICD-8 4463
Cause of death: ICD-10 M35.3
Cause of death: ICD-9 725
Cause of death: ICD-8 4463

2 out of 7 registries used, show all original rules.

3986

diagram downward connector

Check minimum number of events None

3986

diagram downward connector

Include endpoints None

3986

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

3871

diagram downward connector
M13_POLYMYALGIA

Control definitions

Control exclude M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 M35
Name in latin Polymyalgia rheumatica

Summary Statistics

Key figures

All Female Male
Number of individuals 3871 2227 1644
Unadjusted prevalence (%) 0.94 0.97 0.90
Mean age at first event (years) 69.67 68.95 70.66

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.07 3.23 [2.31, 4.51] 7.1e-12 796
15 years 0.01 1.56 [1.21, 2.00] 5.6e-4 298
5 years 0.01 3.78 [3.15, 4.53] 1.8e-46 295
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: M13_POLYMYALGIA – Polymyalgia rheumatica
GWS hits: 1

Survival analyses between endpoints

Plot

before Polymyalgia rheumatica
after Polymyalgia rheumatica

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Polymyalgia rheumatica

Endpoint not on priority list, no data to show.